Predicting risk of drug-resistant organisms in pneumonia: Moving beyond the HCAP model

Additional development and validation of prediction scores based upon more refined risk factors for CAP-DRP is needed. Once an accurate, adequately validated prediction score is available, an interventional trial will be needed to determine clinical impact.